Jash US plant is expected to contribute fully from FY29

Jash Engineering Limited expects its planned US plant to make limited contribution in FY28 and contribute fully in FY29, while existing facilities in India, the US and the UK can support about Rs 1,200 crore of revenue at optimum load levels. Management is expanding Orange capacity for the next one-and-a-half years as an interim measure.

When will Jash's new US plant contribute fully?

Jash said the new US plant may not contribute much in FY28 and should contribute fully from FY29. Management said the facility was expected to be completed around December of the following year, with operations beginning in the last quarter, meaning its initial output would not materially change the FY28 revenue mix.

The construction contract had not been awarded at the time of the call. Jash had appointed a contractor to assess two or three proposals and expected a selection during November, after which work could start from 1 December or according to the selected contractor's execution schedule. Management estimated commissioning would take about 12 months after work began.

In a later response, management gave a separate target of commissioning the plant by the end of March 2028. That date is consistent with a fuller FY29 contribution, but the two timelines leave the final completion date dependent on bid selection and the construction plan.

Can Jash meet US demand before the plant opens?

Jash said its existing manufacturing setup can make and supply the US market's requirements during the current year, including with higher volumes. Management said it had reviewed manufacturing needs with the Jash team at the latest Board meeting and that the team was comfortable with the requirements.

The company is also making minor investments at its Orange facility to support production for at least the next one-and-a-half years. Management described Orange as the bridge between current capacity and the new plant rather than as a substitute for the larger US expansion.

The expansion is intended to respond to two operating factors identified by management: increasing local-manufacturing requirements in the US and labour availability constraints at the existing location. Jash therefore sees the additional site as a way to address both market access and staffing limitations after the interim Orange investments have been used.

How much revenue can Jash's existing network support?

Jash assesses that its present plants in India, the US and the UK can produce about Rs 1,200 crore of revenue at optimum load levels. Management said the new US factory is intended to be available as the company moves towards its subsequent Rs 1,500 crore revenue objective, rather than because current plants cannot meet the immediate production requirement.

The Rs 1,200 crore figure applies to the full existing network, not solely to Orange or the US operation. Management did not disclose a standalone revenue-capacity figure for the new plant, a capacity utilisation level for the current network, or the cost of the minor Orange investments.

Jash also said it was targeting a consolidated pending order book of Rs 1,000 crore to Rs 1,200 crore and expected to cross Rs 1,150 crore in the near term. Management cautioned that project-based orders can make monthly bookings uneven, although it said around Rs 1,000 crore of full-year order booking was possible.

What could affect Jash's US expansion timetable?

The immediate execution variable is contractor appointment. Jash said its appointed reviewer would compare the two or three construction proposals before making a recommendation, and management expected work to begin after selection. The company did not confirm a final project cost when an analyst asked whether an earlier estimate had increased.

Revenue recognition also affected the reported near-term picture. At the end of September, Jash had about Rs 46 crore of dispatched and invoiced orders that could not be recognised because destination-based delivery terms require goods to reach the customer before title transfers. Management said recognising even 50% of that amount in the quarter would have improved the reported result.

For the December quarter, Jash started with the Rs 46 crore spillover and said its standalone business had recorded about Rs 56 crore of revenue in October. Management expected the spillover and ongoing business to support the 90 days ending December, independently of the US plant's construction process.

The US order position provides another operating input. Rodney Hunt had pending order booking of about Rs 391 crore, and management said opportunities in the US remained available despite tariff-related uncertainty affecting the prior year's revenue. Management said it hoped US turnover would reach Rs 35 crore to Rs 36 crore during the year, compared with Rs 25 crore previously.

Conclusion

Jash's capacity plan combines a near-term bridge and a longer-term build. Existing plants in India, the US and the UK are assessed to support about Rs 1,200 crore of revenue, while minor Orange investments are intended to cover the next one-and-a-half years. The planned US plant is therefore positioned to support growth beyond that level, with full contribution expected from FY29.

The next points to watch are the contractor appointment, the start of construction and whether management clarifies the difference between a December completion indication and an end-March 2028 commissioning target. Operationally, Jash's conversion of Rs 46 crore of September in-transit orders, progress towards a Rs 1,150 crore pending order book, and the Orange expansion will indicate how the company manages demand before the new site is fully operational.